Tag: Lubrizol

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol, a global leader in specialty chemistry, has opened a new office in Hammersmith, London. The move reinforces Lubrizol’s commitment to its local-for-local strategy, aiming to enhance collaboration with customers and employees while strengthening its footprint across Europe.

The London office will host a range of business functions, including sales and European leadership, and adds to Lubrizol’s existing presence in the UK, Spain, Belgium, the Netherlands, France, and Germany. It is designed to foster innovation and teamwork, featuring modern co-working and meeting spaces.

“Europe plays a crucial role in our global strategy, particularly due to its concentration of technical leadership and key OEMs,” said Sander van Donk, Vice President of Lubrizol Europe. “The opening of our London office underscores our dedication to this important market.”

With more than 90 years of history in Europe, Lubrizol continues to build on its legacy of innovation and strong industry partnerships. The new office is expected to become a vital hub for the company’s regional operations and future growth.

© 2025 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol has announced a significant milestone: a drug formulation enabled by its Apisolex™ polymer excipient has entered Phase 1 clinical trials. Launched in 2022, Apisolex is a polyamino acid-based polymer designed to dramatically enhance the solubility of challenging active pharmaceutical ingredients (APIs), specifically those classified as BCS Class II and IV.

Manufactured according to Good Manufacturing Practices (GMP), Apisolex is suitable for a variety of dosage forms, including parenteral administration. Its unique formulation has demonstrated the ability to increase the solubility of certain APIs by up to 50,000 times, making it a valuable tool for the development of hard-to-formulate drugs across multiple therapeutic areas and delivery routes.

Apisolex is currently being evaluated in several programs worldwide, supporting the delivery of APIs that have previously posed significant formulation challenges. Kevin Song, Senior Director of Lubrizol’s Global Pharmaceutical and Nutraceutical Business, emphasized the importance of this development: “The progression to clinical trials of a medicinal product formulated with Apisolex polymer excipient demonstrates its ability to provide differentiated solutions to solubility and bioavailability challenges in parenteral formulations.”

Lubrizol is committed to expanding the global reach of Apisolex and strengthening collaborations with drug manufacturers facing solubility hurdles, paving the way for more effective therapies in the future.

© 2025 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Lubrizol, a Berkshire Hathaway company, has announced compelling clinical results for its CURCUSHINE™ microencapsulated curcumin ingredient, which showed significant improvements in skin radiance, wrinkle reduction, and overall skin appearance. The findings, published in Agro FOOD Industry hi-tech, confirm the efficacy of CURCUSHINE™ as a potent beauty-from-within nutraceutical ingredient.

In the study, 63 women aged 21 to 50 with self-reported skin imperfections consumed either CURCUSHINE™ microcapsules or a placebo daily for six weeks. Those taking CURCUSHINE™ experienced a:

19% increase in skin luminosity and up to 69% improvement in skin tone uniformity

8% reduction in dark spots

10.32% average reduction in crow’s feet wrinkle volume

5.14% average reduction in forehead wrinkle volume

Notable improvement in facial skin brightness (L* parameter)

These results build on previous in vitro research demonstrating CURCUSHINE™’s protective effects on collagen and elastin against oxidative and inflammatory stress.

“Aging gracefully is a growing concern among younger adults, including Gen Z and Millennials,” said Isabel Gómez, Global Marketing Manager for Lubrizol Nutraceuticals. “We’re proud to offer a clinically proven solution for skin rejuvenation with CURCUSHINE™.”

CURCUSHINE™ microcapsules are water-dispersible, taste-neutral, and highly bioavailable—making them ideal for a wide range of nutricosmetic formats, including tablets, capsules, gummies, powder sachets, and functional beverages.

© 2025 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol has announced a new distribution partnership with Palmer Holland, Inc., aiming to expand access to its innovative ingredient solutions across the nutraceutical, dietary supplement, and food and beverage markets in the Northeastern United States.

The collaboration is set to meet rising demand for Lubrizol’s microencapsulation technology, which enhances ingredient delivery and bioavailability—key factors in creating effective and enjoyable nutraceutical products. Lubrizol’s European-manufactured portfolio includes branded microcapsules such as LIPOFER™ (iron), MAGSHAPE™ (magnesium), ZINCNOVA™ (zinc), CURCUSHINE™ (curcumin), NEWCAFF™ (caffeine), LIPOPHYTOL™ (phytosterols), and LIPOCAL™ (calcium).

“Recent clinical and consumer studies have confirmed the benefits of our microencapsulation technology in both taste and absorption,” said Ricardo Pereira, Senior Director at Lubrizol. “Through our partnership with Palmer Holland, we can bring these innovations to more consumers.”

Palmer Holland’s Vice President of Consumer & Life Sciences, Bret Horace, added, “Lubrizol’s focus on quality aligns perfectly with our mission to deliver forward-thinking ingredient solutions. Together, we’re enabling the creation of healthier, better-tasting nutraceutical products.”

The partnership marks a strategic step in enhancing product performance and accessibility across a growing health-focused market.

© 2025 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Lubrizol, a subsidiary of Berkshire Hathaway, has announced it will establish a state-of-the-art Technology and Innovation Center in Maharashtra, India. This facility, the first of its kind for Lubrizol globally, aims to drive breakthrough innovations, enhance collaboration, and accelerate market delivery for its customers and industries worldwide.

The new center will integrate various lab capabilities, reinforcing Lubrizol’s in-region Centers of Excellence (COE). It will also house a Customer Experience Center, fostering co-development with customers and partners. Equipped with advanced analytical tools, automation, and digital solutions, the center will apply decision science to fast-track next-generation innovations.

Bhavana Bindra, Lubrizol’s Managing Director for India, the Middle East, and Africa, emphasized the company’s legacy of nearly a century in innovation. She highlighted that the new center underscores Lubrizol’s commitment to technological advancement and collaboration in the region. Dr. Rahul Misra, Senior Director of Technology, further noted that the facility’s location in Maharashtra will enhance efficiency and facilitate cutting-edge research and development.

Lubrizol’s President and CEO, Rebecca Liebert, stated that this center will serve as a model for future global innovation hubs, reinforcing the company’s interconnected research strategy. The Indian innovation teams have already garnered global recognition, and this facility is expected to further amplify their impact.

Lubrizol’s commitment to India spans decades, with notable contributions such as introducing CPVC piping 25 years ago, revolutionizing clean water access. The company’s India-based Bar Soap COE has also driven sustainable improvements in soap formulation. Additionally, Lubrizol continues to develop next-generation additive solutions in response to evolving transportation regulations.

This announcement is part of Lubrizol’s broader investment in India, totaling over $350 million in the past 18 months. The company is constructing its second-largest global manufacturing facility, collaborating on the world’s largest CPVC resin plant, and expanding its operations in Pune and Gujarat. The new Technology and Innovation Center marks another milestone in Lubrizol’s growth and commitment to the Indian market.

© 2025 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol Corporation is ramping up its innovation efforts, leveraging advanced technologies and a dynamic development model to bring solutions to market faster. In 2024, the company invested in data and decision science tools, artificial intelligence (AI), and machine learning (ML) to enhance its speed-to-market capabilities and data-driven insights.

“The biggest shift for Lubrizol is we are now moving faster than ever before,” said Abhishek Shrivastava, VP of Innovation & Decision Science. “We have adopted an agile innovation model—start small, learn fast, fail early, scale quickly. We are not just providing chemistry or products; we are enabling solutions to significant world problems.”

Looking ahead to 2025, Lubrizol plans to launch a strategic external innovation program to foster co-innovation with partners, exploring new solutions for both emerging and existing markets. The company will also expand its labs and R&D capabilities, aiming to unlock even greater opportunities for its customers.

© 2024 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol has announced the promotion of Keith Corkwell to President of Lubrizol Additives, bringing over 25 years of commercial and technical expertise from his career at the company. Previously serving as Vice President, Additives Americas, Corkwell has a deep understanding of the additives industry, spanning fuel additives, heavy-duty engine oils, driveline, e-mobility, and more. His leadership experience has helped guide key product teams across various market segments.

Rebecca Liebert, Lubrizol President and CEO, praised Corkwell for his customer-focused approach and ability to drive results, noting that his leadership will provide tremendous value to the company and its partners.

In addition to Corkwell’s promotion, Lubrizol has made several other key leadership changes:

• Brenna Huovie has been named Vice President, Additives Americas. With nearly 30 years of experience, Huovie will oversee the Americas region, leveraging her expertise in management, technology, and strategic initiatives.

• Mark Davies will assume the role of Vice President, Additives Technology. Davies, with over 20 years at Lubrizol, will lead global innovation efforts, focusing on regionally tailored solutions.

• Anouska Norman has been appointed Vice President, Additives Strategic Marketing and Commercial Excellence. With a wealth of global experience, Norman will drive strategic growth initiatives to enhance Lubrizol’s value to customers.

© 2024 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Lubrizol, a Berkshire Hathaway company, has partnered with Lore Cycle to develop custom 3D-printed cycling shoes that redefine comfort and performance. Using Lubrizol’s advanced thermoplastic polyurethane (TPU) materials and expertise in additive manufacturing through its Avid 3D Printing brand, the collaboration delivers footwear tailored to each rider’s unique foot shape.

The innovative process begins with a 3D scan of the customer’s foot, enabling the creation of personalized components that provide unmatched fit, support, and durability. Lubrizol TPU is used to craft lightweight and robust shoe uppers, ensuring durability without compromising on comfort or performance.

“This collaboration exemplifies how Lubrizol’s 3D printing technology disrupts traditional manufacturing processes, enabling onshoring and delivering unprecedented levels of personalization,” said Gert-Jan Nijhuis, General Manager of Lubrizol 3D Printing.

The Lore Two cycling shoe, Lore Cycle’s latest innovation, is a prime example of this groundbreaking technology. CEO Stephan Drake highlighted its unique features, such as a carbon shell that conforms to the sole, relieves pressure, and optimizes biomechanics.

This partnership showcases the potential of additive manufacturing to transform footwear design, blending cutting-edge technology with material science for truly customized performance gear.

© 2024 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Lubrizol, a Berkshire Hathaway company and global leader in specialty chemicals, has signed a Memorandum of Understanding (MoU) with Polyhose, a global leader in fluid conveyance systems, to bolster innovation in India’s medical sector. The agreement was formalized in the presence of Tamil Nadu Industries Minister Dr. T.R.B. Rajaa and Industries Secretary V. Arun Roy.

The partnership aims to establish a state-of-the-art medical manufacturing facility in Tamil Nadu, increasing Lubrizol’s local medical tubing production by five times. This expansion will cater to domestic and international markets, producing high-quality tubing for critical neurovascular and cardiovascular applications such as balloon and minimally invasive catheters.

“This collaboration introduces precision manufacturing to India, opening new opportunities to serve critical care markets locally and globally,” said Bhavana Bindra, Lubrizol’s Managing Director for India, the Middle East, and Africa. The facility will use Lubrizol’s advanced thermoplastic polyurethane (TPU), known for its biocompatibility and high performance, and comply with ISO 13485 standards.

Lubrizol President and CEO Rebecca Liebert emphasized the company’s commitment to India’s growth, noting the country’s strategic role in its global operations. “This investment strengthens our local-for-local and local-for-global approach, ensuring access to world-class medical solutions,” she said.

The collaboration with Polyhose builds on a seven-year partnership and leverages Tamil Nadu’s industrial growth. Shabbir Y J, Managing Director of Polyhose, highlighted the state’s conducive environment for innovation and expansion.

The project is part of Lubrizol’s broader $350 million investment in India, which includes a Global Capability Center in Pune and major facilities in Gujarat and Aurangabad. Groundbreaking for the Tamil Nadu site is planned for 2025, with operations commencing in 2026.

© 2024 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

The Lubrizol Corporation, part of Berkshire Hathaway, has expanded its partnership with Oil Store, naming it a channel partner for Lubrizol’s refrigeration and heat transfer fluid brands across the U.K., Europe, the Middle East, and North Africa. This move builds on an already successful collaboration in the U.K., aiming to meet increasing demand in new markets.

Lubrizol provides a range of premium fluid engineering brands, including CPI® industrial refrigeration products, Paratherm® heat transfer fluids, and refrigeration solutions such as Emkarate RL®, Icematic®, and Solest®. Through this partnership, Oil Store can now deliver Lubrizol’s technology and solutions across a wider geographic area, addressing specific market needs.

“Reliability is crucial to us, which is why we seek partners who share our commitment to excellence,” said O’Neil Pinto, Vice President of Lubrizol Fluid Engineering. “This collaboration with Oil Store supports our growth and customer service goals.”

Daniel Tait, managing director of Oil Store, praised the success of the initial U.K. partnership, adding, “We are thrilled to extend our services to new regions, maintaining the quality and dedication our U.K. customers have come to trust.”

© 2024 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.